dc.contributor.author | Zahide Şimşek | |
dc.contributor.author | Nazife Candan Tuncer | |
dc.contributor.author | Hakan Alagözlü | |
dc.contributor.author | Fatih Karaahmet | |
dc.contributor.author | Şahin Çoban | |
dc.contributor.author | Ayşe Dursun | |
dc.date.accessioned | 23.07.201910:49:13 | |
dc.date.accessioned | 2019-07-23T16:38:41Z | |
dc.date.available | 23.07.201910:49:13 | |
dc.date.available | 2019-07-23T16:38:41Z | |
dc.date.issued | 2015 | |
dc.identifier.issn | 1300-0144 | |
dc.identifier.uri | http://www.trdizin.gov.tr/publication/paper/detail/TVRjeE1ETXpNdz09 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12418/3753 | |
dc.description.abstract | Background/aim: Irritable bowel syndrome (IBS) is a gastrointestinal condition characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any organic cause. Tis trial investigated the presence of microscopic colitis (MC) and associated factors related to MC in patients diagnosed with IBS. Materials and methods: Te study group (group I) consisted of 91 consecutive patients diagnosed with IBS based on the Rome III Criteria for whom colonoscopic examination was requested. Te control group (group II) had 41 patients diagnosed with IBS considered as eligible for colonoscopic investigation due to specifc conditions, and for whom colonoscopic examination was recommended for screening purposes due to a familial history of colon cancer. Clinical data, endoscopic fndings, and the efects of the therapy were evaluated. Results: In the diarrhea-predominant IBS group, nine patients (9.89%) were diagnosed with microscopic colitis, seven with lymphocytic colitis (7.69%), and two with collagenous colitis (CC) (2.19%). None of the patients in group II were found to have MC (P = 0.007). Tere were no diagnoses of MC in the constipation-predominant and mixed type IBS groups. Conclusion: Clinicians should keep MC in mind for patients presenting with diarrhea-predominant IBS symptoms. | en_US |
dc.description.abstract | Background/aim: Irritable bowel syndrome (IBS) is a gastrointestinal condition characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any organic cause. Tis trial investigated the presence of microscopic colitis (MC) and associated factors related to MC in patients diagnosed with IBS. Materials and methods: Te study group (group I) consisted of 91 consecutive patients diagnosed with IBS based on the Rome III Criteria for whom colonoscopic examination was requested. Te control group (group II) had 41 patients diagnosed with IBS considered as eligible for colonoscopic investigation due to specifc conditions, and for whom colonoscopic examination was recommended for screening purposes due to a familial history of colon cancer. Clinical data, endoscopic fndings, and the efects of the therapy were evaluated. Results: In the diarrhea-predominant IBS group, nine patients (9.89%) were diagnosed with microscopic colitis, seven with lymphocytic colitis (7.69%), and two with collagenous colitis (CC) (2.19%). None of the patients in group II were found to have MC (P = 0.007). Tere were no diagnoses of MC in the constipation-predominant and mixed type IBS groups. Conclusion: Clinicians should keep MC in mind for patients presenting with diarrhea-predominant IBS symptoms. | en_US |
dc.language.iso | eng | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Cerrahi | en_US |
dc.title | Two gastrointestinal conditions with similar symptoms and endoscopic appearance: irritable bowel syndrome and microscopic colitis | en_US |
dc.type | article | en_US |
dc.relation.journal | Turkish Journal of Medical Sciences | en_US |
dc.contributor.department | Sivas Cumhuriyet Üniversitesi | en_US |
dc.identifier.volume | 45 | en_US |
dc.identifier.issue | 2 | en_US |
dc.identifier.endpage | 397 | en_US |
dc.identifier.startpage | 393 | en_US |
dc.relation.publicationcategory | Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı | en_US] |